Matthew C. Zorn previously argued that federal regulators determine "accepted medical use" through the FDA approval framework. Today, he appears on behalf of the United States defending a CMS progr...
MMJ International Holdings: CMS EXPOSED: The "Workaround Doctrine" - How Matt Zorn's Legal CMS Hemp Strategy Undermines the FDA
